Zhongchao (ZCMD) Other Non-Current Liabilities (2021 - 2022)
Zhongchao (ZCMD) reported Other Non-Current Liabilities of $37.2 million for Q4 2022, up 2.53% year-over-year from $36.3 million in Q4 2021, and up 2.53% quarter-over-quarter from $36.3 million in Q4 2021.
Zhongchao (ZCMD) Other Non-Current Liabilities (2021 - 2022) Analysis & Trends
Zhongchao (ZCMD) has 2 years of Other Non-Current Liabilities data on file, last reported at $37.2 million in Q4 2022.
- Other Non-Current Liabilities for Q4 2022 came in at $37.2 million, up 2.53% year-over-year; the trailing twelve-month figure through Dec 2022 was $37.2 million (up 2.53% YoY), and the FY2022 annual result was $37.2 million, up 2.53% from the prior year.
- Other Non-Current Liabilities climbed to $37.2 million in Q4 2022 per ZCMD's latest filing, from $36.3 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $37.2 million in Q4 2022 and troughed at $36.3 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn |
| 10 | Zhongchao | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 37.18 Mn |
| Dec 31, 2021 | 36.27 Mn |